NEW YORK -New research shows stents coated with the antibiotic sirolimus are more effective in preventing restenosis - the renarrowing of blood vessels after an angioplasty.
The RAVEL trial, conducted by the Institut Cardiovasculaire Paris Sud, examined 238 patients. Half of the patients received coated stents, while the others received uncoated stents. One year after the procedure, 94 percent of those who received coated stents were restenosis free and had not had a major cardiac event, in comparison to 71 percent of those who received an uncoated stent.
Siroliums was approved by the Food and Drug Administration (FDA) in 1999 to prevent kidney transplant rejection.
Information from www.reuters.com
Broadening the Path: Diverse Educational Routes Into Infection Prevention Careers
July 4th 2025Once dominated by nurses, infection prevention now welcomes professionals from public health, lab science, and respiratory therapy—each bringing unique expertise that strengthens patient safety and IPC programs.
How Contaminated Is Your Stretcher? The Hidden Risks on Hospital Wheels
July 3rd 2025Despite routine disinfection, hospital surfaces, such as stretchers, remain reservoirs for harmful microbes, according to several recent studies. From high-touch areas to damaged mattresses and the effectiveness of antimicrobial coatings, researchers continue to uncover persistent risks in environmental hygiene, highlighting the critical need for innovative, continuous disinfection strategies in health care settings.